Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-15-066079
Filing Date
2015-09-18
Accepted
2015-09-18 18:37:04
Documents
1
Period of Report
2015-09-16

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4005
  Complete submission text file 0001104659-15-066079.txt   5201
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PREDIX PHARMACEUTICALS HOLDINGS, INC. 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address
Schor Chen (Reporting) CIK: 0001340875 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 151116247